Amferia's peptide-based hydrogel boosts antibiotic effectiveness by up to 64 times against resistant bacteria, stabilizing ...

Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 Dec.

Orano Med, a subsidiary of the Orano Group, has begun construction of an Advanced Thorium Extraction Facility (ATEF) in ...

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental Biologics License ...

Last week saw US pharma major AbbVie release disappointing Phase II trial results on its emraclidine in schizophrenia, which ...

US antiviral giant Gilead Sciences on Friday unveiled two-and-a-half-year interim analysis from the ongoing Phase III ASSURE ...

French drugmaker Ipsen (Euronext: IPN) announced late-breaking data for Iqirvo (elafibranor 80mg tablets) from an interim ...

Johnson & Johnson has filed a lawsuit seeking validation of its rebate model for 340B drugs, which offers post-sale rebates instead of upfront discounts. The initiative, criticized by hospitals and ...

Zai Lab has priced its public offering at $25.50 per share, targeting $200 million for corporate purposes. The fundraising ...

The MHRA has approved Novavax’s updated Nuvaxovid vaccine for the latest subvariant in individuals aged 12 and older. This ...

South Korean biosimilars company Celltrion today announced its acquisition of iQone Healthcare Switzerland a specialty ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) made a number of recommendations at its November ...